[1] |
De Leyn P, Lardinois D, Van Schil PE,et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer[J]. Eur J Cardiothorac Surg, 2007,32(1):1-8.
|
[2] |
Zhi XY,Wu YL, Bu H,et al. Chinese guidelines on the diagnosis and treatment of primary lung cancer[J]. J Thorac Dis, 20 12,4(1):88-101.
|
[3] |
Wu YL,Huang ZF,Rong TH. Mediastinoscopy for clinical undifferentiated thoracic disease [J]. Zhongguo Xiong Xin Xue Guan Wai Ke Za Zhi, 1998,14(1):28-30. [吴一龙,黄植蕃,戎 铁华.胸部疑难疾病的纵隔镜检查[J]. 中华胸心血管外科杂 志,1998,14(1):28-30.]
|
[4] |
Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) [J]. Chest,2007,132(3 Suppl):202S-220S.
|
[5] |
Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition) [J]. Chest,2007,132(3 Suppl):178S-201S.
|
[6] |
Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography [J]. N Engl J Med, 2003,348(25):2500-7.
|
[7] |
Lv YL, Yuan DM, Wang K, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis [J]. J Thorac Oncol, 2011, 6(8):1350-8.
|
[8] |
Wang SX. PET/CT for N2 staging in non-small cell lung cancer [J] Zhongguo Fei Ai Za Zhi, 2008,11(5):646-8. [王淑侠. 非 小细胞肺癌N2无创分期:PET/CT分期[ J ] .中国肺癌杂 志,2008,11(5):646-8. ]
|
[9] |
Darling GE,Maziak DE,Inculet RI, et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial [J]. J Thorac Oncol, 2011,6(8):1367-72.
|
[10] |
Tasci E, Tezel C, Orki A, et al. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer [J]. Interact Cardiovasc Thorac Surg, 2010,10(2):200-3.
|
[11] |
Lee JW, Kim BS, Lee DS, et al. 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity [J]. Eur J Nucl Med Mol Imaging, 2009, 36(11):1794-802.
|
[12] |
Gdeedo A, Van Schil P, Corthouts B, et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging[J]. Eur Respir J,1997, 10(7):1547-51.
|
[13] |
Hammoud ZT,Anderson RC,Meyers BF,et al.The current role of mediastinoscopy in the evaluation of thoracic disease[J]. J Thorac Cardiovasc Surg, 1999, 118(5):894-9.
|
[14] |
Lemaire A, Nikolic I, Petersen T, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate [J]. Ann Thorac Surg, 2006, 82(4):1185-9.
|
[15] |
Ernst A,Anantham D,Eberhardt,et al.Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy [J]. J Thorac Oncol, 2008, 3( 6):577-82.
|
[16] |
Liao RQ, Yang XN, Wang BC, et al. Diagnosis and staging of mediastinal lymphadenopathy: EBUS-TBNA versus mediastinoscopy[J]. Zhongguo Zhong Liu Lin Chuang,2011, 38 (24):1501-4. [廖日强,杨学宁,汪斌超,等. EBUS-TBNA和纵隔 镜检查术在纵隔淋巴结诊断与分期中的对照研究[J].中国肿瘤 临床,2011,38(24):1501-4.]
|
[17] |
Shrager JB. Mediastinoscopy: still the gold standard[J]. Ann of Thorac Surg, 2010, 89(6):S2084-9.
|
[18] |
Van Schil PE, De Waele M. A second mediastinoscopy: how to decide and how to do it? [J]. Euro J of Cardiothorac Surg, 2008, 33 (4):703-6.
|